Abstract Introduction and aims Atopic dermatitis (AD) is a chronic skin condition ranked the 15th highest global burden for all nonfatal diseases. Our lab has found that patients with AD have a reduction in the gene and protein expression of cathepsin H, a lysosomal cysteine protease with aminopeptidase activity. Ctsh-/- mice have a reduced integrity of the epidermal barrier, including reduced filaggrin processing, reduced corneocyte integrity and a change in the expression of several proinflammatory mediators including interleukin-1α. We aim to elucidate the roles of cathepsin H in keratinocytes to understand its contribution to the pathogenesis of AD. Methods We utilized rat epidermal and N/TERT keratinocytes transiently overexpressing procathepsin B, H or L in addition to incubating keratinocytes with cathepsin H inhibitor (CTSHi) for 24 h to identify potential substrates and proteins upregulated or downregulated with cathepsin H expression. We also performed colocalization studies using indirect immunofluorescence in rat epidermal keratinocytes (REKs) and N/TERTs to investigate the biology of cathepsin H. Results REKs transiently overexpressing procathepsin H-FLAG or FLAG and REKs treated with the cathepsin H inhibitor H2N-Ser(OBzl)-CHN2 were analysed by liquid chromatography-mass spectrometry. This analysis indicated that keratin 1 and keratin 9 were upregulated with cathepsin H expression and downregulated by cathepsin H inhibition. Overexpressed procathepsin H and endogenous cathepsin H do not colocalize with the lysosomal membrane protein, LAMP1, whereas endogenous cathepsin B does. Conclusions Keratin 1 and keratin 9 could be coregulated with cathepsin H. Cathepsin H may not primarily localize to lysosomes unlike cathepsin B.